BIOMAT Database Logo BIOMAT Database Logo

[Continuous subcutaneous desferrioxamine infusions in patients with hemosiderosis (author's transl)]. 1982

W Tillmann, and R König, and K Schröder, and W Schröter

UI MeSH Term Description Entries
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003676 Deferoxamine Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form. Desferrioxamine,Deferoxamine B,Deferoxamine Mesilate,Deferoxamine Mesylate,Deferoxamine Methanesulfonate,Deferoximine,Deferrioxamine B,Desferal,Desferioximine,Desferrioxamine B,Desferrioxamine B Mesylate,Desferroxamine,Mesilate, Deferoxamine,Mesylate, Deferoxamine,Mesylate, Desferrioxamine B,Methanesulfonate, Deferoxamine
D006486 Hemosiderosis Conditions in which there is a generalized increase in the iron stores of body tissues, particularly of liver and the MONONUCLEAR PHAGOCYTE SYSTEM, without demonstrable tissue damage. The name refers to the presence of stainable iron in the tissue in the form of hemosiderin. Hemosideroses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000741 Anemia, Aplastic A form of anemia in which the bone marrow fails to produce adequate numbers of peripheral blood elements. Anemia, Hypoplastic,Aplastic Anaemia,Aplastic Anemia,Anaemia, Aplastic,Aplastic Anaemias,Aplastic Anemias,Hypoplastic Anemia,Hypoplastic Anemias
D013789 Thalassemia A group of hereditary hemolytic anemias in which there is decreased synthesis of one or more hemoglobin polypeptide chains. There are several genetic types with clinical pictures ranging from barely detectable hematologic abnormality to severe and fatal anemia. Thalassemias

Related Publications

W Tillmann, and R König, and K Schröder, and W Schröter
[Treatment of iron overload due to repeated transfusions with subcutaneous infusions of desferrioxamine (author's transl)].
April 1980, Archives francaises de pediatrie,
W Tillmann, and R König, and K Schröder, and W Schröter
Evaluation of continuous desferrioxamine administration in adults with transfusional hemosiderosis.
January 1977, Transactions of the Association of American Physicians,
W Tillmann, and R König, and K Schröder, and W Schröter
[Desferrioxamine in patients with hemochromatosis and hemosiderosis].
January 1966, Revista do Hospital das Clinicas,
W Tillmann, and R König, and K Schröder, and W Schröter
Delayed decrease in serum ferritin in polytransfused children with thalassemia major after continuous subcutaneous infusions of desferrioxamine.
January 1981, Acta haematologica,
W Tillmann, and R König, and K Schröder, and W Schröter
[Experiences with continuous infusions of etomidate in cardiac surgery (author's transl)].
August 1976, Der Anaesthesist,
W Tillmann, and R König, and K Schröder, and W Schröter
Continuous subcutaneous infusions of opiates in cancer patients with pain.
January 1986, Oncology nursing forum,
W Tillmann, and R König, and K Schröder, and W Schröter
Treatment of hemodialysis hemosiderosis with desferrioxamine.
January 1982, Transactions - American Society for Artificial Internal Organs,
W Tillmann, and R König, and K Schröder, and W Schröter
An alternative to continuous subcutaneous infusion of desferrioxamine in thalassaemic patients.
September 1997, British journal of haematology,
W Tillmann, and R König, and K Schröder, and W Schröter
[Continuous subcutaneous pH monitoring in newborns with abnormal metabolism (author's transl)].
July 1975, Geburtshilfe und Frauenheilkunde,
W Tillmann, and R König, and K Schröder, and W Schröter
Iron absorption in iron-loading anaemias: Effect of subcutaneous desferrioxamine infusions.
October 1977, Lancet (London, England),
Copied contents to your clipboard!